Blog
Collection and handling of thoracic small biopsy and cytology specimens for ancillary studies
July 2020 By M.Angeles Montero, BTOG Steering Committee Member From 2011 and updated in 2015, the identification of therapeutic targets for the...
Lifelong learning
February 2020 By Dr Adam Januszewski, Higher Specialty Trainee in Medical Oncology and Honorary Clinical Fellow, Imperial College London On...
Palliative care – why go to BTOG?
February 2020 By Dr Antonia Field-Smith, Consultant in Palliative Medicine, West Middlesex University Hospital Despite all the recent successes with...
Full of ideas following BTOG 2020
February 2020 By Dr Helen McDill, Respiratory Registrar and Interventional Respiratory Fellow, Derriford Hospital, Plymouth NHS Trust What a...
Checkmate-227 study at ESMO 2019
November 2019 By Tom Newsom-Davis, BTOG Vice-Chair 1st Line Combination Immunotherapy for NSCLC: Checkmate-227 Further results from the...
FLAURA study at ESMO 2019
November 2019 By Tom Newsom-Davis, BTOG Vice-Chair 1st Line Osimertinib Overall Survival Results: FLAURA The overall survival (OS) date from the...
Medical Oncology at WCLC 2019
October 2019 By Tom Newsom-Davis, BTOG Vice-Chair Treatment of RET-Fusion NSCLC: LIBRETTO-001 RET fusions are found in a number of different cancer...
Lung Cancer Screening at the WCLC 2019 Presidential Symposium: aiming to cure
September 2019 By Dr Matthew Callister, Consultant Respiratory Physician A year after the preliminary publication of the NELSON screening...
Mesothelioma Essential Update 2019
March 2019 By Liz Darlison, Head of Services and Clinical Nurse Specialist for Mesothelioma UK and Professor James Spicer, BTOG Steering Committee...